Global Pneumococcal Vaccine Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q3 2018 Update)
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Stakeholders
2. Research & Forecasting
- 2.1. Research Methodology
- 2.1.1. Research Instruments
- 2.1.1.1. Secondary Instrument
- 2.1.1.2. Primary Instrument
- 2.1.2. Research Approaches
- 2.1.2.1. Bottom-up Approach
- 2.1.2.2. Top-down Approach
- 2.1.3. Research Reliability & Validity
- 2.1.4. Research Assumptions
- 2.1.5. Vendor Inclusion Criteria
- 2.1.1. Research Instruments
- 2.2. Forecasting Methodology
- 2.2.1. Methodology for Market Estimation & Forecasting
- 2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
- 4.1. Market Connectivity
- 4.2. Market Data Feed
- 4.3. Market Vendor Ranking Analysis
- 4.4. Market Dynamics
- 4.4.1. Drivers
- 4.4.2. Restraints
- 4.4.3. Opportunities
- 4.4.4. Challenges
- 4.5. Porter’s Five Forces Analysis
- 4.5.1. Threat of New Entrants
- 4.5.2. Threat of Substitutes
- 4.5.3. Bargaining Power of Customers
- 4.5.4. Bargaining Power of Suppliers
- 4.5.5. Industry Rivalry
5. Global Pneumococcal Vaccine Market, by Indication
- 5.1. Introduction
- 5.2. Bronchitis
- 5.3. Meningitis
- 5.4. Pneumonia
- 5.5. Sepsis
6. Global Pneumococcal Vaccine Market, by Type
- 6.1. Introduction
- 6.2. Conjugate Vaccines
- 6.3. Polysaccharide Vaccines
7. Global Pneumococcal Vaccine Market, by Geography
- 7.1. Introduction
- 7.2. Americas Pneumococcal Vaccine Market
- 7.2.1. Americas Pneumococcal Vaccine Market, by Country
- 7.2.1.1. United States
- 7.2.1.2. Brazil
- 7.2.1.3. Canada
- 7.2.1.4. Mexico
- 7.2.1.5. Argentina
- 7.2.2. Americas Pneumococcal Vaccine Market, by Indication
- 7.2.3. Americas Pneumococcal Vaccine Market, by Type
- 7.2.1. Americas Pneumococcal Vaccine Market, by Country
- 7.3. Europe, Middle East & Africa Pneumococcal Vaccine Market
- 7.3.1. Europe, Middle East & Africa Pneumococcal Vaccine Market, by Country
- 7.3.1.1. United Kingdom
- 7.3.1.2. Germany
- 7.3.1.3. France
- 7.3.1.4. Saudi Arabia
- 7.3.1.5. United Arab Emirates
- 7.3.1.6. Italy
- 7.3.1.7. Russia
- 7.3.2. Europe, Middle East & Africa Pneumococcal Vaccine Market, by Indication
- 7.3.3. Europe, Middle East & Africa Pneumococcal Vaccine Market, by Type
- 7.3.1. Europe, Middle East & Africa Pneumococcal Vaccine Market, by Country
- 7.4. Asia-Pacific Pneumococcal Vaccine Market
- 7.4.1. Asia-Pacific Pneumococcal Vaccine Market, by Country
- 7.4.1.1. China
- 7.4.1.2. Japan
- 7.4.1.3. India
- 7.4.1.4. Australia
- 7.4.2. Asia-Pacific Pneumococcal Vaccine Market, by Indication
- 7.4.3. Asia-Pacific Pneumococcal Vaccine Market, by Type
- 7.4.1. Asia-Pacific Pneumococcal Vaccine Market, by Country
8. Competitive Strategic Window
- 8.1. Introduction
- 8.1.1. Leverage Zone
- 8.1.2. Vantage Zone
- 8.1.3. Speculative Zone
- 8.1.4. Bottleneck Zone
9. FPNV Positioning Matrix
- 9.1. Introduction
- 9.2. Scores
- 9.2.1. Forefront
- 9.2.2. Pathfinders
- 9.2.3. Niche
- 9.2.4. Vital
- 9.3. Business Strategy
- 9.4. Product Satisfaction
10. Competitive News Feed Analysis
11. Company Usability Profiles
- 11.1. Astellas Pharma Inc.
- 11.2. AstraZeneca PLC
- 11.3. Baxter International Inc.
- 11.4. CSL Limited
- 11.5. Emergent BioSolutions Inc.
- 11.6. GlaxoSmithKline plc
- 11.7. Johnson & Johnson
- 11.8. Merck & Co., Inc.
- 11.9. Pfizer Inc.
- 11.10. Sanofi Pasteur MSD
- 11.11. Serum Institute of India Pvt. Ltd.
12. Appendix
- 12.1. Top Reports
- 12.2. Author Details
LIST OF TABLES (26 TABLES)
TABLE 1. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET RANKING, BY VENDORS, 2017
TABLE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 12. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 13. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)
TABLE 14. AMERICAS PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 16. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)
TABLE 17. EUROPE, MIDDLE EAST & AFRICA PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 18. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 19. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2016 - 2024 (USD MILLION)
TABLE 20. ASIA-PACIFIC PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2016 - 2024 (USD MILLION)
TABLE 21. 360IRESEARCH SCORES FOR FOREFRONT IN PNEUMOCOCCAL VACCINE MARKET
TABLE 22. 360IRESEARCH SCORES FOR PATHFINDERS IN PNEUMOCOCCAL VACCINE MARKET
TABLE 23. 360IRESEARCH SCORES FOR NICHE IN PNEUMOCOCCAL VACCINE MARKET
TABLE 24. 360IRESEARCH SCORES FOR VITAL IN PNEUMOCOCCAL VACCINE MARKET
TABLE 25. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR PNEUMOCOCCAL VACCINE MARKET
TABLE 26. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR PNEUMOCOCCAL VACCINE MARKET
LIST OF FIGURES (24 TABLES)
FIGURE 1. GLOBAL PNEUMOCOCCAL VACCINE MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PNEUMOCOCCAL VACCINE MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL PNEUMOCOCCAL VACCINE MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL PNEUMOCOCCAL VACCINE MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL PNEUMOCOCCAL VACCINE MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL PNEUMOCOCCAL VACCINE MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL PNEUMOCOCCAL VACCINE MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL PNEUMOCOCCAL VACCINE MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL PNEUMOCOCCAL VACCINE MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. PNEUMOCOCCAL VACCINE MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 12. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY INDICATION, 2017 VS 2024 (USD MILLION)
FIGURE 13. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY BRONCHITIS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 14. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY MENINGITIS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 15. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY PNEUMONIA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 16. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY SEPSIS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 17. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY TYPE, 2017 VS 2024 (USD MILLION)
FIGURE 18. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY CONJUGATE VACCINES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 19. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY POLYSACCHARIDE VACCINES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 20. GLOBAL PNEUMOCOCCAL VACCINE MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 21. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY INDICATION, 2024
FIGURE 22. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY TYPE, 2024
FIGURE 23. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PNEUMOCOCCAL VACCINE MARKET, BY GEOGRAPHY, 2024
FIGURE 24. 360IRESEARCH FPNV POSITIONING MATRIX FOR PNEUMOCOCCAL VACCINE MARKET
The global pneumococcal vaccine market is expected to grow from USD 6,485.35 million 2017 to USD 9,854.35 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 6.16%.
On the basis of indication, the global pneumococcal vaccine market is studied across Bronchitis, Meningitis, Pneumonia, and Sepsis.
On the basis of type, the global pneumococcal vaccine market is studied across Conjugate Vaccines and Polysaccharide Vaccines.
On the basis of geography, the global pneumococcal vaccine market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia).
“Astellas Pharma Inc.: The potential growing player for the global pneumococcal vaccine market”
The key players profiled in the global pneumococcal vaccine market are Astellas Pharma Inc., AstraZeneca PLC, Baxter International Inc., CSL Limited, Emergent BioSolutions Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Sanofi Pasteur MSD, and Serum Institute of India Pvt. Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global pneumococcal vaccine market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global pneumococcal vaccine market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global pneumococcal vaccine market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global pneumococcal vaccine market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global pneumococcal vaccine market.